publication venue for Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control.. 18:113-125. 2015 Utilization and cost comparison of erythropoiesis-stimulating agents in inpatient and outpatient hospital settings.. 15:352-360. 2012 Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.. 13:673-680. 2010
